In our study, although no statistical significance was found, drug-refractory epilepsy showed a trend of increased incidence in the positive genetic test group compared with the negative genetic test group, which was likely because drug-refractory epilepsy was more likely have a genetic etiology, such as has been reported for PCDH19 ( 20 ) and SCN1A gene mutations ( 21 ), which carry a greater risk of drug-refractory epilepsy.
← all excerpts
The Clinical and Genetic Features of Co-occurring Epilepsy and Autism Spectrum Disorder in Chinese Children.
1
—
—